Acute Rejection After Kidney Transplant-An Endpoint Not Predictive of Treatment Effect on Graft Survival

被引：4

作者：

Fitzsimmons, William E. ^{[1
,2
]}

Naesens, Maarten ^{[3
,4
]}

机构：

[1] Univ Illinois, Dept Pharm Syst Outcomes & Policy, Coll Pharm, Chicago, IL USA

[2] Univ Illinois, Dept Physiol & Biophys, Coll Med, Chicago, IL USA

[3] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium

[4] UZ Leuven, Dept Nephrol, Leuven, Belgium

来源：

TRANSPLANTATION | 2024年 / 108卷 / 03期

关键词：

LONG-TERM; MYCOPHENOLATE-MOFETIL; PHASE-III; RENAL-TRANSPLANTATION; TACROLIMUS FK506; FOLLOW-UP; CYCLOSPORINE; PREVENTION; IMMUNOSUPPRESSION; RECIPIENTS;

D O I：

10.1097/TP.0000000000004696

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：593 / 597

页数：5

共 27 条

[1]

Behrend M, 1999, TRANSPLANTATION, V68, P391

[2] Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study [J].

Budde, K. ;

Lehner, F. ;

Sommerer, C. ;

Reinke, P. ;

Arns, W. ;

Eisenberger, U. ;

Wuethrich, R. P. ;

Muehlfeld, A. ;

Heller, K. ;

Porstner, M. ;

Veit, J. ;

Paulus, E. -M. ;

Witzke, O. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (01) :119-128

[3] Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. [J].

Bumgardner, GL ;

Hardie, I ;

Johnson, RWG ;

Lin, A ;

Nashan, B ;

Pescovitz, MD ;

Ramos, E ;

Vincenti, F .

TRANSPLANTATION, 2001, 72 (05) :839-845

[4]

Cho S, 1999, AM J KIDNEY DIS, V34, P296

[5] Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation [J].

Ekberg, H. ;

Bernasconi, C. ;

Tedesco-Silva, H. ;

Vitko, S. ;

Hugo, C. ;

Demirbas, A. ;

Reyes Acevedo, R. ;

Grinyo, J. ;

Frei, U. ;

Vanrenterghem, Y. ;

Daloze, P. ;

Halloran, P. F. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (08) :1876-1885

[6]

European Medicines Agency, 2022, EMADOC-1700519818-946771

[7]

European Medicines Agency, 2008, CHMPEWP26314806

[8]

European Medicines Agency, iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients

[9]

GRINYO J, 1995, LANCET, V345, P1321

[10] Alemtuzumab Induction in Renal Transplantation [J].

Hanaway, Michael J. ;

Woodle, E. Steve ;

Mulgaonkar, Shamkant ;

Peddi, V. Ram ;

Kaufman, Dixon B. ;

First, M. Roy ;

Croy, Richard ;

Holman, John .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20) :1909-1919

← 1 2 3 →